Charles River Laboratories
CRL
#1935
Rank
NZ$17.20 B
Marketcap
NZ$349.61
Share price
-0.57%
Change (1 day)
20.48%
Change (1 year)
Categories

Market capitalization of Charles River Laboratories (CRL)

Market cap: NZ$17.20 Billion

As of February 2026 Charles River Laboratories has a market cap of NZ$17.20 Billion. This makes Charles River Laboratories the world's 1935th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Charles River Laboratories from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$17.20 B-0.58%
2025NZ$17.30 B2.53%
2024NZ$16.87 B-11.97%
2023NZ$19.17 B9.81%
2022NZ$17.46 B-37.27%
2021NZ$27.83 B61.61%
2020NZ$17.22 B55.19%
2019NZ$11.09 B36.46%
2018NZ$8.13 B11.45%
2017NZ$7.29 B40.21%
2016NZ$5.20 B-5.09%
2015NZ$5.48 B42.69%
2014NZ$3.84 B25.24%
2013NZ$3.06 B39.75%
2012NZ$2.19 B26.86%
2011NZ$1.73 B-33.41%
2010NZ$2.60 B-14.91%
2009NZ$3.05 B0%
2008NZ$3.05 B-47.79%
2007NZ$5.85 B42.47%
2006NZ$4.10 B-8.41%
2005NZ$4.48 B5.75%
2004NZ$4.24 B75.37%
2003NZ$2.41 B-27.25%
2002NZ$3.32 B-8.71%
2001NZ$3.64 B64.13%
2000NZ$2.21 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Charles River Laboratories was reported to be:

NZ$17.20 Billion
by Nasdaq info icon info icon
NZ$17.20 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Thermo Fisher Scientific
TMO
NZ$361.08 B 1,998.57%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
NZ$49.55 M-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$13.96 B-18.83%๐Ÿ‡บ๐Ÿ‡ธ USA